About the Company
Angion Biomedica Corp. is committed to transforming the treatment paradigm for patients suffering from acute organ injuries and fibrotic diseases for which there are no approved medicines or where existing approved medicines have limitations. Angion’s lead product candidate, ANG-3777, is a hepatocyte growth factor (HGF) mimetic currently being evaluating in a Phase 3 registration trial for delayed graft function in patients undergoing deceased donor kidney transplantation, a Phase 2 trial in cardiac-surgery associated acute kidney injury, and a Phase 2 trial in patients with COVID-19 related pneumonia at high risk for acute respiratory distress syndrome. Angion is also currently evaluating ANG-3070, a tyrosine kinase receptor inhibitor for the treatment of fibrotic disease, in Phase 1. Additionally, Angion has preclinical programs for a rho kinase 2 (ROCK2) inhibitor and a CYP11B2 (aldosterone synthase) inhibitor.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ANGN News
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
Angion Biomedica Corp. (NASDAQ:ANGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address fibrotic diseases ...
Corporation: What It Is and How To Form One
A corporation is a legal entity that is separate and distinct from its owners. Under the law, corporations possess many of the same rights and responsibilities as individuals. They can enter ...
LLC vs. corporation: Differences, pros and cons
The two most common corporation types are C corporations (C corps) and S corporations (S corps). C corps are what we generally think of as traditional corporations, subject to double taxation ...
Clover Corp.
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company focuses on the delivery of bioactive ingredients using ...
Bank First Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
S-Corp vs LLC: How To Discern What You Need
Although you have several options, many business owners narrow their choice down to an S-corp vs. an LLC. Although S-corps and LLCs share some similar features, both come with their own set of ...
C-Corp vs LLC: What’s the Difference?
These two formal business entities provide limited liability protections for their owners. A corporation is often referred to as a C-corporation or C-corp. Learn about the differences between a C ...
Duke Energy Corp DUK
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Chesapeake Energy Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Scales Corp.
Scales Corp. Ltd. is a agribusiness group that operates and provides services to New Zealand's primary export sector. It operates though the following segments: food ingredients, horticulture ...
Comcast Corp. Cl A
Liberty Media Corp. Series C Liberty Formula One 0.93% $27.06B Liberty Media Corp. Series A Liberty Formula One 0.79% $27.06B Liberty Broadband Corp. Cl A 0.34% $7.14B Liberty Broadband Corp. Cl C ...
Devon Energy Corp DVN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...